FGFR3 expression is considered an independent prognostic factor affecting the overall survival (p < 0.001) and the progression-free survival (p = 0.003) in patients with ESCC by Cox multivariate regression analysis. Here, FGFR3 is linked to esophageal squamous cell carcinoma.